2seventy bio, Inc.

TSVT · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Activities
Net Income-$57-$218-$254-$292
Dep. & Amort.$7$10$12$16
Deferred Tax$0$0$0$0
Stock-Based Comp.$12$32$41$55
Change in WC$3$3-$36$13
Other Non-Cash-$50$6$0$1
Operating Cash Flow-$85-$167-$237-$207
Investing Activities
PP&E Inv.-$1-$14-$23-$20
Net Acquisitions$0$0-$35$0
Inv. Purchases-$127-$247-$146$0
Inv. Sales/Matur.$167$305$180$35
Other Inv. Act.$42-$0$35-$33
Investing Cash Flow$81$44$12$15
Financing Activities
Debt Repay.$0$0$0$0
Stock Issued$0$127$166$7
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$0$1$1$355
Financing Cash Flow$0$127$166$355
Forex Effect$0$0$0$0
Net Chg. in Cash-$4$4-$59$163
Supplemental Information
Beg. Cash$77$72$163$0
End Cash$73$77$104$163
Free Cash Flow-$86-$181-$260-$227
2seventy bio, Inc. (TSVT) Financial Statements & Key Stats | AlphaPilot